Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2020168118. doi: 10.1073/pnas.2020168118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33495337
Free PMC article.